Literature DB >> 6793771

PRL, TSH, and thyroid hormones in benign breast diseases.

F Peters, C R Pickardt, G Zimmermann, M Breckwoldt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6793771     DOI： 10.1007/BF01698519

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  26 in total

1.  Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors:  G L Noel; H K Suh; J G Stone; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

2.  Thyroid status and breast cancer. Reappraisal of an old relationship.

Authors:  A R Moossa; D A Evans; A C Brewer
Journal:  Ann R Coll Surg Engl       Date:  1973-09       Impact factor: 1.891

3.  [Breast neoplasms and thyroid therapy].

Authors:  D Reinwein
Journal:  Dtsch Med Wochenschr       Date:  1980-04-25       Impact factor: 0.628

4.  Studies on clinical, hormonal and pathological correlations in breast fibroadenomas.

Authors:  P M Martin; F Kuttenn; H Serment; P Mauvais-Jarvis
Journal:  J Steroid Biochem       Date:  1978-12       Impact factor: 4.292

5.  [Alimentary iodine deficiency in the Federal Republic of Germany (author's transl)].

Authors:  J Habermann; H G Heinze; K Horn; R Kantlehner; I Marschner; J Neumann; P Scriba
Journal:  Dtsch Med Wochenschr       Date:  1975-09-26       Impact factor: 0.628

6.  Response of serum prolactin to exogenous stimulation.

Authors:  D F Archer; J B Josimovich
Journal:  Fertil Steril       Date:  1975-07       Impact factor: 7.329

7.  Hyperprolactinaemia and luteal insufficiency.

Authors:  M Seppälä; T Ranta; E Hirvonen
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

8.  Premenstrual tension and functional infertility. Aetiology and treatment.

Authors:  L J Benedek-Jaszmann; M D Hearn-Sturtevant
Journal:  Lancet       Date:  1976-05-22       Impact factor: 79.321

9.  [Clinical experimental studies in the treatment of ovarian dysfunction with bromo-ergocryptin (pravidel) (author's transl)].

Authors:  K Diedrich; F Leidenberger; F Lehmann; G Bettendorf
Journal:  Geburtshilfe Frauenheilkd       Date:  1978-09       Impact factor: 2.915

10.  Prolactin concentrations in patients with breast cancer.

Authors:  S Franks; D N Ralphs; V Seagroatt; H S Jacobs
Journal:  Br Med J       Date:  1974-11-09
View more
  7 in total

1.  Luteal phase defect and breast cancer genesis.

Authors:  P Mauvais-Jarvis; R Sitruk-Ware; F Kuttenn
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

2.  The use of bromocriptine in the management of non-puerperal mastitis.

Authors:  F Peters; M Hilgarth; M Breckwoldt
Journal:  Arch Gynecol       Date:  1982

Review 3.  Benign breast diseases.

Authors:  Carine Courtillot; Geneviève Plu-Bureau; Nadine Binart; Corinne Balleyguier; Brigitte Sigal-Zafrani; Vincent Goffin; Frédérique Kuttenn; Paul A Kelly; Philippe Touraine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

4.  A systematic review of current understanding and management of mastalgia.

Authors:  Kamal Kataria; Anita Dhar; Anurag Srivastava; Sandeep Kumar; Amit Goyal
Journal:  Indian J Surg       Date:  2013-02-05       Impact factor: 0.656

5.  Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.

Authors:  E Parlati; A Travaglini; I Liberale; E Menini; S Dell'Acqua
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

6.  Role of centchroman in regression of mastalgia and fibroadenoma.

Authors:  Anita Dhar; Anurag Srivastava
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

Review 7.  An alternative yogic approach for cyclical mastalgia-A narrative review.

Authors:  Garima Jaiswal; Ghanshyam S Thakur
Journal:  J Family Med Prim Care       Date:  2021-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.